title: Influence of serum from rats with fulminant hepatic failure on hepatocytes in a bioartificial liver system.
abstract: Fulminant hepatic failure (FHF) is a life-threatening condition marked by many excessively increased unmetabolized toxins and growth factors. Recently developed bioartificial liver (BAL) systems containing hepatocytes can be used to treat patients with FHF However, the behavior of these hepatocytes on exposure to FHF serum in vitro remains unclear. In the present study, we used FHF rat models and the sera from these rats (i.e., FHF serum) contained elevated inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6), HGF, and TGF-beta1. In addition, 1x10(8) hepatocytes were harvested from the livers of inbred rats and incubated with microcarrier beads. Four hours later, the hepatocyte-coated beads were inoculated into a hollow-fiber module (=BAL system). FHF serum or normal control serum circulated for 6 hours through the BAL system. Expressions of mRNA for albumin, GST A1, CYP 1A2, OTC and c-fos were investigated by RT-PCR, and PCNA staining was performed before and after perfusion. The expressions of albumin, GST A1, and CYP 1A2 mRNAs were markedly decreased, whereas those of OTC and c-fos were modestly decreased. PCNA positive cells were low and showed no difference between FHF and normal serum-exposed hepatocytes. In conclusion, the exposure of hepatocytes to hypercytokinemia, including inflammatory cytokines and positive and negative growth factors, caused a loss in liver specific functions. This environment also failed to facilitate hepatocyte regeneration.
authors.affiliation: Department of Transplantation and Digestive Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. hae37010@ams.odn.ne.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Ito
authors.forename: S
authors.initials: S
authors.lastname: Eguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Kamohara
authors.forename: H
authors.initials: H
authors.lastname: Inuo
authors.forename: K
authors.initials: K
authors.lastname: Yamanouchi
authors.forename: S
authors.initials: S
authors.lastname: Okudaira
authors.forename: K
authors.initials: K
authors.lastname: Yanaga
authors.forename: J
authors.initials: J
authors.lastname: Furui
authors.forename: T
authors.initials: T
authors.lastname: Kanematsu
mesh_terms: D000818:Animals; D016207:Cytokines / Q000032:analysis; D004195:Disease Models, Animal; D015536:Down-Regulation; D022781:Hepatocytes / Q000502:physiology*; D017093:Liver Failure / Q000097:blood*; D008115:Liver Regeneration / Q000502:physiology; D019164:Liver, Artificial; D008297:Male; D010477:Perfusion; D011336:Probability; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011917:Rats, Inbred Lew; D018709:Statistics, Nonparametric; D020858:Tissue and Organ Harvesting / Q000379:methods
chemical_list: D016207:Cytokines; D012333:RNA, Messenger